Novo Nordisk reported 90.28B in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
Bausch Health Companies USD 2.21B 138M Jun/2025
Bristol-Myers Squibb USD 15.1B 515M Jun/2025
Eli Lilly USD 17.21B 3.2B Jun/2025
GlaxoSmithKline GBP 7.7B 196M Jun/2025
Merck USD 12.72B 1.14B Jun/2025
Novartis USD 9.18B 451M Jun/2025
Novo Nordisk 90.28B 3.92B Jun/2025
Novo Nordisk DKK 86.37B 6.74B Mar/2025
Pacira USD 114.37M 9.62M Jun/2025
Sanofi 8.21B 7.76B Jun/2025
Supernus Pharmaceuticals USD 140.83M 4.81M Jun/2025